INNA GABAY: Open Payments
NPI 1992784896 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$263 in 9 payments from 4 companies in 2025. Trend: 2023 $36 · 2024 $280 · 2025 $263
Food & beverage: $263
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $103 |
| Neurocrine BioSciences, Inc. | 2 | $73 |
| Almatica Pharma LLC | 3 | $64 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: INVEGA SUSTENNA, INGREZZA, LOREEV XR, Auvelity.
Industry payments across NY — which companies pay providers there.
